Concepedia

Daniel Kuessner

DK

Statistics

Publications

6

Citations

293

H-Index

6

Active since

2011

Affiliations

Basilea Pharmaceutica (Switzerland)(Current)

Covance (United Kingdom)

Heidelberg University

Daniel Kuessner is an author at Basilea Pharmaceutica (Switzerland) specializing in pharmacoeconomics, antifungal pharmacotherapy, and medicine.

Publications per year

2011–2019

6

Publications

6

The Burden and Impact of Vertigo: Findings from the REVERT Patient Registry

Heike Benecke, Sam Agus, Daniel Kuessner et al. · Frontiers in Neurology · 2013 · 130 citations · Full text

Medicine, Otolaryngology, Occupational Health +13

Cost‐of‐illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany

Matthias Augustin, Daniel Kuessner, S. Purwins et al. · British Journal of Dermatology · 2011 · 55 citations

Medicine, Dermatology, Pharmacoeconomics +14

Cost-of-illness Analysis of Patients with Chronic Hand Eczema in Routine Care in Germany: Focus on the Impact of Occupational Disease

Thomas L. Diepgen, S. Purwins, Jan Posthumus et al. · Acta Dermato Venereologica · 2013 · 41 citations · Full text

Medicine, Dermatology, Insurance +17

Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden

Lefteris Floros, Daniel Kuessner, Jan Posthumus et al. · BMC Infectious Diseases · 2019 · 28 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

The Cost of Treating Mucormycosis with Isavuconazole Compared with Standard Therapy in the UK

Emma Bagshaw, Daniel Kuessner, Jan Posthumus et al. · Future Microbiology · 2017 · 23 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

1–5 of 6